A comprehensive view of Elanco Animal Health Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pet Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Stifel upgrades Elanco Animal Health to buy, predicts its stock could rise another 27%, on top of 80% gain over past two months; significant revenue growth expected until 2025, bolstered by canine treatments such as Zenrelia and Quattro

Elanco Animal Health's Bexacat product wins Overall Cat Health Product of the Year at Pet Innovation Awards for improving glycemic control in diabetic cats; as first oral prescription tablet of its kind, Bexacat eliminates need for insulin injections

Ask us about our Pet Care market view

Trending Chart

Interactive chart with headline count